Table 4.
Cross-correlation matrix (Spearman rank correlation coefficients) generated by comparing gene expression levels with clinical parameters of the cortical dysplasia cohort
| CCL5 | CCL22 | CCL23 | CXCL9 | CXCL10 | FasL | FLAIR | IFN-γ | T2 | Time | AED | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
CCL5 |
1.00 |
−0.16 |
0.26 |
0.3 |
0.06 |
0.17 |
−0.02 |
0.06 |
−0.15 |
0.36 |
0.43 |
|
CCL22 |
|
1.00 |
−0.01 |
−0.02 |
0.06 |
0.08 |
0.04 |
0.03 |
−0.4 |
0.03 |
−0.31 |
|
CCL23 |
|
|
1.00 |
0.3 |
−0.19 |
0.57 |
0.21 |
0.1 |
0.16 |
0.12 |
0.22 |
|
CXCL9 |
|
|
|
1.00 |
0.08 |
0.49 |
0.16 |
−0.46 |
−0.1 |
−0.05 |
0.08 |
|
CXCL10 |
|
|
|
|
1.00 |
−0.12 |
−0.26 |
−0.2 |
−0.42 |
0.13 |
0.04 |
|
FasL |
|
|
|
|
|
1.00 |
0.37 |
−0.15 |
0.39 |
0.23 |
0.56 |
|
FLAIR |
|
|
|
|
|
|
1.00 |
0.18 |
0.41 |
0.57 |
0.25 |
|
IFN-γ |
|
|
|
|
|
|
|
1.00 |
−0.04 |
0.62a |
0.31 |
|
T2 |
|
|
|
|
|
|
|
|
1.00 |
0.18 |
0.13 |
|
Timeb |
|
|
|
|
|
|
|
|
|
1.00 |
0.51 |
| AED | 1.00 |
aStatistically significant correlation is in bold type (P < 0.05). bTime from seizure onset to surgery.
AED, antiepileptic drugs.